Venova Medical develops minimally invasive vascular access technology for hemodialysis patients.
Founded in 2018 by Erik van der Burg and Shant Vartanian, Venova Medical is based in California, US. Its Velocity™ Percutaneous Arterio-Venous Fistula System is designed to provide vascular access for hemodialysis patients. In September 2024, the company raised USD 30 million in Series B funding co-led by Catalyst Health Ventures, with ShangBay Capital, Mirae Asset Capital, KOFA Healthcare Investments, Cadence Healthcare Ventures, and Aphelion Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in